Perceptive Advisors invests $100mm in Athenex through stock and debt agreement

15:40 EDT 6 Jul 2018 | Elsevier Business Intelligence

Perceptive Advisors invested $100mm in cancer therapeutics developer Athenex Inc. The firm purchased 2.68mm common shares at ...

More From BioPortfolio on "Perceptive Advisors invests $100mm in Athenex through stock and debt agreement"